Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine
BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine
BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine
Submitted by
admin
on April 3, 2014 - 9:17am
Source:
Yahoo/Benzinga
News Tags:
clonidine
BioDelivery Sciences
diabetic neuropathy
Headline:
BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine
Do Not Allow Advertisers to Use My Personal information
